All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2016-001176-30 | Effects of PCSK9 inhibition by Evolocumab on postprandial lipid metabolism in type 2 diabetes Evolokumabin vaikutus aterian jälkeiseen rasva-aineenvaihduntaan tyypin 2 diabetesta sairastavilla hen... | 2021-01-12 | due-trials |